Fei Xu

机构：Sun Yat-sen University, Wuhan Union Hospital, Sun Yat-sen University Cancer Center, First Hospital of Lanzhou University, Union Hospital, Lanzhou University, Nanjing Medical University · ORCID：0000-0001-8543-6636

发表论文 196 篇 · 总被引 4274 次 · h-index 34

代表论文

• Current insights and assumptions on α-synuclein in Lewy body disease (2024 · Acta Neuropathologica · 被引 30)
• Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis (2024 · Clinics and Research in Hepatology and Gastroenterology · 被引 27)
• OTULIN confers cisplatin resistance in osteosarcoma by mediating GPX4 protein homeostasis to evade the mitochondrial apoptotic pathway (2024 · Journal of Experimental & Clinical Cancer Research · 被引 15)
• Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: The Phase III MECCA Trial (2025 · Journal of Clinical Oncology · 被引 12)
• Bevacizumab, tislelizumab and nab-paclitaxel for previously untreated metastatic triple-negative breast cancer: a phase II trial (2025 · Journal for ImmunoTherapy of Cancer · 被引 10)
• Mechanistic insights into the co-extraction of lithium and gallium from high-alumina fly ash via Na2CO3 roasting and HCl leaching: A thermodynamic perspective (2025 · Separation and Purification Technology · 被引 8)